Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis

By sjmartinez • July 31, 2023

Karpouzas GA, Papotti B, Ormseth SR, Palumbo M, Hernandez E, Adorni MP, Zimetti F, Budoff MJ, Ronda N. Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis. J Transl Autoimmun. 2023 Jul 18;7:100209. doi: 10.1016/j.jtauto.2023.100209. PMID: 37520890; PMCID: PMC10371792.

Tags: ABCA1, Cardiology/Epi, Cardiovascular events, Cholesterol efflux capacity, Coronary Atherosclerosis, Corticosteroids, Harbor UCLA, Publications, Rheumatoid arthritis, Rheumatology

Barriers and Emerging Strategies to Bridge Gaps in Implementation of Evidence-Based Lipid-Lowering Therapies

Marnell CS, Koenig W, Bittner V, Watson KE, Muntner P, Nordestgaard BG, Yan LL, Verbakel M, Rosenson RS. Barriers and Emerging Strategies to Bridge Gaps[...]

New 10-Year Atherosclerosis Cardiovascular Disease Risk Score for Asian and American Indian Women Service Members

Jeon-Slaughter H, Whyne EZ, Doyle C, Chen X, Chiou SH, Tsai S, Ebrahimi R. New 10-Year Atherosclerosis Cardiovascular Disease Risk Score for Asian and American[...]

Cardiovascular disease mortality among women diagnosed with de novo metastatic breast cancer

Ramin C, Gresham G, Li J, Karlstaedt A, Hashibe M, Nikolova AP, Atkins KM. Cardiovascular disease mortality among women diagnosed with de novo metastatic breast[...]